MXPA05001051A - Composiciones anti-microbianas y metodos para usar las mismas. - Google Patents

Composiciones anti-microbianas y metodos para usar las mismas.

Info

Publication number
MXPA05001051A
MXPA05001051A MXPA05001051A MXPA05001051A MXPA05001051A MX PA05001051 A MXPA05001051 A MX PA05001051A MX PA05001051 A MXPA05001051 A MX PA05001051A MX PA05001051 A MXPA05001051 A MX PA05001051A MX PA05001051 A MXPA05001051 A MX PA05001051A
Authority
MX
Mexico
Prior art keywords
turmeric
extract
ginger
green tea
antimicrobial composition
Prior art date
Application number
MXPA05001051A
Other languages
English (en)
Spanish (es)
Inventor
Richard A Rosenbloom
Original Assignee
The Quigley Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/024794 external-priority patent/WO2003013428A2/fr
Priority claimed from US10/359,889 external-priority patent/US7396546B2/en
Application filed by The Quigley Corp filed Critical The Quigley Corp
Publication of MXPA05001051A publication Critical patent/MXPA05001051A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA05001051A 2002-08-06 2003-07-24 Composiciones anti-microbianas y metodos para usar las mismas. MXPA05001051A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2002/024794 WO2003013428A2 (fr) 2001-08-06 2002-08-06 Complements nutritionnels et leurs procedes d'utilisation
US10/359,889 US7396546B2 (en) 2001-08-06 2003-02-06 Anti-microbial compositions and methods of using same
PCT/US2003/023125 WO2004012655A2 (fr) 2002-08-06 2003-07-24 Compositions antimicrobiennes et procedes d'utilisation correspondants

Publications (1)

Publication Number Publication Date
MXPA05001051A true MXPA05001051A (es) 2005-04-08

Family

ID=34549101

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05001051A MXPA05001051A (es) 2002-08-06 2003-07-24 Composiciones anti-microbianas y metodos para usar las mismas.

Country Status (10)

Country Link
EP (1) EP1545470A4 (fr)
JP (1) JP2005534699A (fr)
CN (1) CN1674875A (fr)
AU (1) AU2003256736B2 (fr)
CA (1) CA2495447A1 (fr)
HK (1) HK1082660A1 (fr)
IL (1) IL166608A0 (fr)
MX (1) MXPA05001051A (fr)
NZ (1) NZ537821A (fr)
WO (1) WO2004012655A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166435B2 (en) 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
NZ526098A (en) * 2003-05-23 2005-10-28 Enzo Nutraceuticals Ltd Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine
JP2008505901A (ja) * 2004-07-07 2008-02-28 三井農林株式会社 耐久性のある殺生物剤および消毒剤
JP4788994B2 (ja) * 2005-01-26 2011-10-05 独立行政法人農業・食品産業技術総合研究機構 機能性飲食品
JP5032003B2 (ja) * 2005-06-15 2012-09-26 株式会社琉球バイオリソース開発 口腔粘膜用の鎮痛・抗炎症トローチ剤
FR2887748B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires.
FR2887749B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires
KR101351674B1 (ko) * 2005-09-30 2014-01-14 디에스엠 아이피 어셋츠 비.브이. 폴리페놀을 함유하는 신규 조성물
PT1993577E (pt) * 2006-03-10 2014-05-27 Nutricia Nv Uso de sacarídeos não digestivos para proporcionar a uma criança o melhor começo após o nascimento
JP5207341B2 (ja) * 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 炎症性サイトカイン産生抑制剤
MX2009006395A (es) * 2006-12-14 2009-06-23 The Quigley Corp Metodos para tratar y reducir la incidencia de la enfermedad de newcastle.
CN101557815A (zh) * 2006-12-14 2009-10-14 奎格利公司 用于治疗传染性支气管炎的组合物和方法
KR101077920B1 (ko) 2009-07-08 2011-10-31 한국생명공학연구원 울금 추출물을 포함하는 인플루엔자 바이러스 감염의 예방 및 치료용 조성물 및 뉴라미니데이즈 활성의 억제용 조성물
KR101121615B1 (ko) 2009-09-14 2012-02-28 주식회사 바이오에프디엔씨 항균용 세정제 조성물
KR100962334B1 (ko) * 2009-10-19 2010-06-10 주식회사 중앙백신연구소 울금으로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
EP2490703B1 (fr) 2009-10-22 2015-09-09 Maresins Pharma, Inc. Composition à base d'herbe médicinale comprenant du gingembre et de la verge d'or pour le traitement d'une infection d'influenza
ITMI20111259A1 (it) * 2011-07-06 2013-01-07 Eye Tech Srl Composizione orosolubile a rapida disgregazione contenente derivati di curcumina
JP2013100253A (ja) * 2011-11-09 2013-05-23 Shigeru Abe ショウガ成分を含む抗カンジダ活性組成物
US20140294990A1 (en) * 2013-03-27 2014-10-02 Timothy P. O'Connor Throat gargle tablet and method of use thereof
EP3103465A1 (fr) 2015-06-10 2016-12-14 Raman Mehta Formulations pour le traitement de lésions de muqueuses
JP2019011279A (ja) * 2017-06-30 2019-01-24 小林製薬株式会社 下痢抑制剤
CN117338758B (zh) * 2023-12-06 2024-03-12 北京远大九和药业有限公司 一种药物组合物及其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6032705A (ja) * 1983-08-02 1985-02-19 Shiraimatsu Shinyaku Kk 抗微生物剤
JPH02276562A (ja) * 1989-04-19 1990-11-13 Mitsui Norin Kk 抗菌剤
JPH0319670A (ja) * 1989-06-17 1991-01-28 Chieko Shiroi ウコン混合の穀物及びその加工食品
CN1060012A (zh) * 1991-09-20 1992-04-08 沈阳市铁西区科发医药饮料技术服务部 一种口香糖的制作方法
CN1072823A (zh) * 1992-06-13 1993-06-09 文士开 果酶茶的配制方法
JP2540719B2 (ja) * 1993-10-21 1996-10-09 有限会社ビオールケミカル 茶の葉
CN1116068A (zh) * 1994-01-25 1996-02-07 刘俊松 天然乳化果茶主剂的制备方法
JPH10130161A (ja) * 1996-09-06 1998-05-19 Otsuka Pharmaceut Co Ltd ヘリコバクター・ピロリに対する組成物
JPH10279432A (ja) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The 組成物
JPH11302121A (ja) * 1998-04-16 1999-11-02 Fuudeiamu Tokunaga:Kk 緑茶カテキンを用いた抗菌剤
JP2000212094A (ja) * 1998-11-18 2000-08-02 Takeda Chem Ind Ltd 口腔用製剤
JP2000157209A (ja) * 1998-11-27 2000-06-13 Kagetoshi Kawauchi 振り掛け健康食品
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6264995B1 (en) * 1999-10-19 2001-07-24 Thomas Newmark Herbal composition for reducing inflammation and methods of using same
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it

Also Published As

Publication number Publication date
AU2003256736A1 (en) 2004-02-23
WO2004012655A3 (fr) 2004-09-16
JP2005534699A (ja) 2005-11-17
EP1545470A2 (fr) 2005-06-29
NZ537821A (en) 2007-05-31
WO2004012655A2 (fr) 2004-02-12
CA2495447A1 (fr) 2004-02-12
IL166608A0 (en) 2006-01-15
CN1674875A (zh) 2005-09-28
HK1082660A1 (zh) 2006-06-16
EP1545470A4 (fr) 2009-07-01
AU2003256736B2 (en) 2009-09-10

Similar Documents

Publication Publication Date Title
AU2002332464B2 (en) Nutritional supplements and methods of using same
US6827945B2 (en) Nutritional supplements and methods of using same
US7396546B2 (en) Anti-microbial compositions and methods of using same
AU2003256736B2 (en) Anti-microbial compositions and methods of using same
AU2002332464A1 (en) Nutritional supplements and methods of using same
US7175987B2 (en) Compositions and methods for treatment of herpes
US7507425B2 (en) Method for the treatment of cachexia
Darakhshan et al. Nigella sativa: A plant with multiple therapeutic implications
Mahmood et al. Foeniculum vulgare, Solanum nigrum and Cichorium intybus: A Collectanea of Pharmacological and Clinical uses
Barik et al. Management of asthma by herbal therapy with special reference to polyherbal formulation.
KR20050033069A (ko) 항생 조성물 및 그 사용 방법
FR3057777A1 (fr) Composition a visee expectorante et decongestionnante des voies respiratoires, son procede de preparation et son utilisation
Sao et al. Assesment of Antidiabetic and Liver Protective effect of “sankat mochan drops”: A Polyherbal Marketed Formulation
RATHOUR et al. Review on Syzygium cumini Linn: A promising ethnopharmacological plant.
ZA200500517B (en) Anti-microbial compositions and methods of using same.
Rufaida et al. Foeniculum vulgare, Solanum nigrum and Cichorium intybus: a collectanea of pharmacological and clinical uses.
Ajayan et al. Scientific Rationale for the Use of Single Herb Remedies in Ayurveda
Ajayan et al. 5 Scientifc Rationale for the Use of Single Herb Remedies in Ayurveda
Laekeman Assessment report on Cinnamomum verum JS Presl, cortex and corticisaetheroleum
Jain et al. HERBAL XEROGEL
Nongbet et al. Phytochemistry, Pharmacological Activities, Nanoparticles Synthesis, Commercial Exploration and Valorization of Endangered Medicinal Plant Embelia ribes Burm.: A Review
Saeed et al. PHARMACOLOGICAL ACTIVITIES OF GINGER (ZINGIBER OFFICINALE): A REVIW